Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, but I wish that I did. LOL.
kool-aid? You must have been bombed out of your mind on the DKAM Vodka those same guys were pumping 2 years ago at 2 and 3 dollars. LOL.
http://finance.yahoo.com/echarts?s=DKAM.OB#chart1:symbol=dkam.ob;range=5y;indicator=volume;charttype=line;crosshair=on;ohlcvalues=0;logscale=on;source=undefined
Your post forced Van Jones to resign. LOL.
http://www.weaselzippers.net/blog/2009/09/van-jones-resigns.html
I have a question on the masks. Do you plan on buying masks and wearing them? I have only seen one person wearing a mask and that was at the airport.
I guess that I am not. I'm showing a bid of .102 and an ask of .19.
That is a strange stock. 86% between the bid and the ask and the bid is 70% below the last trade.
I am NOT going to explode. LOL.
GAPPER=RTK
biot, What do you think of ISR? They had HUGE news about a week ago and the stock has formed a nice pennent. Check out this chart.
http://stockcharts.com/h-sc/ui?s=isr
Here is a link to last weeks news.
http://finance.yahoo.com/news/IsoRay-Announces-FDA-bw-2922557333.html?x=0&.v=1
biotplaya, Boy that is a hard question. Back when it was under $1, I would have said load the boat, in fact that is what I was trying to say Monday night since I have basically quit giving stock tips on message boards. The YMI Yahoo mesage board is full of pumppers saying that it will go to $20 or $50. Biotech as you know has been HOT in the last 3 or 4 months. It has been the place to be. I think the big key to the success of this company is getting a partner in the USA that will give them a big upfront payment and a big payment upon FDA approval. Until that happens, I would say the top is $5. If that happens, $15 easily. After this big run, I would be carefull as to how much you invest. At this point I would just try to catch a trade with a close stop.
tomcatgreenman, I agree with you on all points. However, about the girls, I would like a better look at the one that is drinking the beer. She looks like she could be HOT too, you just can't see because of the beer mug. LOL.
YMI hit $1.98 this morning. That is a 100% gain since my post on Monday night. Post is one click back. Next VPHM?
GRVY I don't think that this report will be received very well. If I recall, they earned something like 15 cents in the last quarter.
New jobless claims and total benefit rolls drop
From Associated Press
August 27, 2009 8:40 AM EDT
WASHINGTON - The government says the number of newly laid-off workers filing claims for jobless benefits dropped last week, and the number of people remaining on the rolls also fell, evidence that layoffs have eased.
Still, both figures remain above levels associated with a healthy economy, and analysts expect the unemployment rate to keep rising.
The Labor Department said Thursday first-time unemployment claims fell to a seasonally-adjusted 570,000, down from an upwardly revised figure of 580,000 the previous week. Analysts expected a slightly larger drop to 565,000.
The tally of those continuing to claim benefits dropped to 6.13 million from 6.25 million in the previous week, the lowest level since early April.
I guess that was bradford's rumor. With all of the price increases in the last quarter, earnings should be stellar.
YMI Nice article on Dow Jones news wire today.
By Shara Tibken
Of DOW JONES NEWSWIRES
NEW YORK (Dow Jones)--Shares of YM BioSciences Inc. (YMI) soared 68% Tuesday on nearly 11 times the normal daily volume.
Analysts said they weren't sure what was driving the stock higher, and the company said in a statement that its policy is not to comment on unusual market activity.
Shares closed up 67 cents, or 68%, at $1.66, a fresh 52-week high. In March, shares were trading as low as 20 cents, but they have more than quadrupled year-to-date and have nearly tripled in the past 12 months.
Earlier this month, shares soared after the company received clearance from the U.S. Treasury to develop its nimotuzumab drug for clinical development in any cancer indication. The drug has its origins in Cuba, which meant it previously was banned from the U.S.
Desjardins Securities analyst Maher Yaghi said the go-ahead from the U.S. will allow it to expand its research and also have better success in finding partners for the drug.
"It does broaden the molecule's interest for major pharma," Yaghi said in an interview.
He added that the embargo on Cuban products meant that even if a drug has positive trial results and works, it can't be sold in the U.S.
"But that's not a problem anymore," Yaghi said, adding the drug is still in the early stages of development.
Meanwhile, Griffin Securities analyst Chrystyna Bedrij in a note Monday reiterated her buy rating on the company and established a 12-month price target of $5, saying results from recent nimotuzumab studies show a favorable risk-benefit profile when compared with other drugs.
"We believe the implications of these findings and the related value to both cancer patients and shareholders are potentially substantial given that nimotuzumab will prospectively be an important competitor to Erbitux, whose 2008 sales were $1.5 billion, and for which Eli Lilly [& Co.] (LLY) recently acquired ImClone Systems for $6 billion," Bedrij noted.
She added 20 clinical trials around the world have been completed for nimotuzumab, and it's already approved for sale in India, China, Indonesia, the Philippines and 16 other developing countries.
That, when coupled with the recent green light by the U.S. government and other factors, makes upside for nimotuzumab and YM "exceptional," Bedrij said.
Sentiment : Strong Buy
It is almost like the old RB days. LOL.
p3, Re:YMI. It could easily be worth $50 mil up fromt payment and 10% royalties and then $100 Mil on FDA approval.
The Health care plan.
Let me get this straight.
>>
>> Obama's health care plan will be written by a committee whose head
>> says he doesn't understand it, passed by a Congress that hasn't read
>> it and whose members will be exempt from it, signed by a president who
>> smokes, funded by a treasury chief who did not pay his taxes, overseen
>> by a surgeon general who is obese, and financed by a country that is
>> broke.
>>
>> What could possibly go wrong?
Maybe it is the next VPHM. Anyway, it sure looked like it today.
You call 22 mil shares lack of volume?
GAPPER=CNO
I'm in at 87 cents. At 12:30 today that was a 66% gain in 6 trading days. I think the key to this one is that they get a partner in the US that will give them an up front payment of like $50 mil and 10% royalties on sales in the US.
YMI OK if you guys don't want to take credit for YMI 's rise, I will. LOL. Here is a post that I made on a different board yesterday.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=40825411
YMI---Here is a biotech stock that has a cancer drug approved for sale in 12 countries. Because this company is in Cuba, they needed approval from the US government before they could further develope it in the USA. They received approval on 8-10-2009.
http://finance.yahoo.com/news/Ym-Biosciences-Usa-Receives-prnews-1938394081.html?x=0&.v=7
This company sells for under $1.00 and has 77 cents in cash per share. As with most low priced biotech's, they have NO earnings. There were 7 firms that follow this company and their mean target price is $6.50 per share. A new firm/analyst put out a $5 target price today. the analyst/firm is Griffen Securities.
https://commerce.us.reuters.com/purchase/showReportDetail.do?docid=46304005
Hope that some got my latest pick on the zipp code changer board.
Hope that you doubled down on YMI at the open today.
In your case it looks like a good time to "double down".
Are you sure it was me that pitched it the last time? I must have old timmers disease because I don't ever remember pitching YMI before. The only biotech stocks that I ever remember pitching were VPHM and AGEN.
Sorry, I forgot to give the stock symbol first.
YMI---Here is a biotech stock that has a cancer drug approved for sale in 12 countries. Because this company is in Cuba, they needed approval from the US government before they could further develope it in the USA. They received approval on 8-10-2009.
http://finance.yahoo.com/news/Ym-Biosciences-Usa-Receives-prnews-1938394081.html?x=0&.v=7
This company sells for under $1.00 and has 77 cents in cash per share. As with most low priced biotech's, they have NO earnings. There were 7 firms that follow this company and their mean target price is $6.50 per share. A new firm/analyst put out a $5 target price today. the analyst/firm is Griffen Securities.
https://commerce.us.reuters.com/purchase/showReportDetail.do?docid=46304005
Here is a biotech stock that has a cancer drug approved for sale in 12 countries. Because this company is in Cuba, they needed approval from the US government before they could further develope it in the USA. They received approval on 8-10-2009.
http://finance.yahoo.com/news/Ym-Biosciences-Usa-Receives-prnews-1938394081.html?x=0&.v=7
This company sells for under $1.00 and has 77 cents in cash per share. As with most low priced biotech's, they have NO earnings. There were 7 firms that follow this company and their mean target price is $6.50 per share. A new firm/analyst put out a $5 target price today. the analyst/firm is Griffen Securities.
https://commerce.us.reuters.com/purchase/showReportDetail.do?docid=46304005
Hope that they do better with their presentation than GRVY did.
Traderfan, Did you ever find out what the rumor is?
R59, Being a trader myself, I can understand locking in profits when you get 100% in less than a week. Congratulations. Can you say what percentage that you sold? CPQQ earnings are over 2x LPIH and look where LPIH is today. Prospects for both companies appears to be excellent.
Well that is a given. That never stopped him from posting before. Maybe he has sand in the keyboard.
Where is Buzz? We are in the biggest rally in the market since the 1930's and I haven't seen Buzz post here since 6-22.
GAPPER=FNM for same reason Sulpher is picking FRE.
GRVY, Bob, You might say the stock is defying Gravity. They present at some money show tomorrow and Saturday in San Francisco.
Since I bot ORS in PSL at the absolute high, I hope that these earnings can get it back to that high so that I can get out of the basement in this contest.
Cliff, It sounds to me like these I-Hub posters are taking the questions brought up on this board back to TRTN management and then TRTN management says oh yeah we ought to do that. This is a guy that is supposed to have an IQ of 176.